The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports
Open accessAbstract
BACKGROUND The epidemiology of mucormycosis in the era of modern diagnostics is relatively under-explored. OBJECTIVES To examine the contemporary epidemiology, clinical manifestations, diagnosis and causative pathogens of mucormycosis. DATA SOURCES Ovid MEDLINE and Ovid EMBASE from January 2000 to January 2017. STUDY ELIGIBILITY CRITERIA Published case reports/series of proven/probable mucormycosis. PARTICIPANTS Patients ≥18 years old. METHODS Patient characteristics, disease manifestations and causative pathogens were summarized descriptively. Categorical variables were assessed by chi-square test or Fischer's exact test, and continuous variables by the Wilcoxon-Mann-Whitney or Kruskal-Wallis test. Risk factors for the different clinical manifestations of mucormycosis were identified using multivariate logistic regression. RESULTS Initial database searches identified 3619 articles of which 600 (851 individual patient cases) were included in the final analysis. Diabetes mellitus was the commonest underlying condition (340/851, 40%) and was an independent risk for rhino-orbital-cerebral mucormycosis (odds ratio (OR) 2.49; 95% CI 1.77-3.54; p < 0.001). Underlying haematological malignancy was associated with disseminated infection (OR 3.86; 95% CI 1.78-8.37; p 0.001), whereas previous solid organ transplantation was associated with pulmonary (OR 3.19; 95% CI 1.50-6.82; p 0.003), gastrointestinal (OR 4.47; 95% CI 1.69-11.80; p 0.003), or disseminated (OR 4.20; 95% CI 1.68-10.46; p 0.002) mucormycosis. Eight genera (24 species) of Mucorales organisms were identified in 447/851 (53%) cases, of which Rhizopus spp. (213/447, 48%) was the most common. Compared with other genera, Rhizopus spp. was predominantly observed in patients with rhino-orbital-cerebral mucormycosis (75/213, 35% versus 34/234, 15%; p < 0.001). Death was reported in 389/851 (46%) patients. Mortality associated with Cunninghamella infections was significantly higher than those caused by other Mucorales (23/30, 71% versus 185/417, 44%; p < 0.001). However, Cunninghamella spp. were isolated primarily in patients with pulmonary (17/30, 57%) or disseminated disease (10/30, 33%). CONCLUSIONS Findings from the current review have helped ascertain the association between various manifestations of mucormycosis, their respective predisposing factors and causative organisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044
Ribes, J. A., Vanover-Sams, C. L., & Baker, D. J. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.236 · Cited by 1,711
Morrison, A., Polisena, J., Husereau, D., Moulton, K., Clark, M., Fiander, M., Mierzwinski-Urban, M., Clifford, T., Hutton, B., & Rabb, D. (2012) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462312000086 · Cited by 1,257
Skiada, A., Pagano, L., Groll, A., Zimmerli, S., Dupont, B., Lagrou, K., Lass-Florl, C., Bouza, E., Klimko, N., Gaustad, P., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03456.x · Cited by 748
Kontoyiannis, D. P., Lionakis, M. S., Lewis, R. E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T. J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428780 · Cited by 674
The clinical case report: a review of its merits and limitations
Nissen, T., & Wynn, R. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-264 · Cited by 636
A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)
Lanternier, F., Dannaoui, E., Morizot, G., Elie, C., Garcia-Hermoso, D., Huerre, M., Bitar, D., Dromer, F., Lortholary, O., & the French Mycosis Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir880 · Cited by 527
Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species
Gomes, M. Z. R., Lewis, R. E., & Kontoyiannis, D. P. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-10 · Cited by 443
Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010
Bitar, D., Lortholary, O., Le Strat, Y., Nicolau, J., Coignard, B., Tattevin, P., Che, D., & Dromer, F. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.140087 · Cited by 426
Walsh, T. J., Gamaletsou, M. N., McGinnis, M. R., Hayden, R. T., & Kontoyiannis, D. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir868 · Cited by 386
The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus
Chakrabarti, A., Das, A., Mandal, J., Shivaprakash, M. R., George, V. K., Tarai, B., Rao, P., Panda, N., Verma, S. C., & Sakhuja, V. (2006) · Medical Mycology · doi:10.1080/13693780500464930 · Cited by 376
Kontoyiannis, D. P., & Lewis, R. E. (2011) · Blood · doi:10.1182/blood-2011-03-316430 · Cited by 376
Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011
Neblett Fanfair, R., Benedict, K., Bos, J., Bennett, S. D., Lo, Y.-C., Adebanjo, T., Etienne, K., Deak, E., Derado, G., Shieh, W.-J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204781 · Cited by 360
Invasive Non- Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006
Park, B. J., Pappas, P. G., Wannemuehler, K. A., Alexander, B. D., Anaissie, E. J., Andes, D. R., Baddley, J. W., Brown, J. M., Brumble, L. M., Freifeld, A. G., et al. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110087 · Cited by 321
Mucormycosis in hematologic patients.
Pagano, L., Offidani, M., Fianchi, L., Nosari, A., Candoni, A., Picardi, M., Corvatta, L., D’Antonio, D., Girmenia, C., Martino, P., et al. (2004) · PubMed · Cited by 302
Healthcare-Associated Mucormycosis
Rammaert, B., Lanternier, F., Zahar, J.-R., Dannaoui, E., Bougnoux, M.-E., Lecuit, M., & Lortholary, O. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir867 · Cited by 282
Millon, L., Herbrecht, R., Grenouillet, F., Morio, F., Alanio, A., Letscher-Bru, V., Cassaing, S., Chouaki, T., Kauffmann-Lacroix, C., Poirier, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.006 · Cited by 260
Millon, L., Larosa, F., Lepiller, Q., Legrand, F., Rocchi, S., Daguindau, E., Scherer, E., Bellanger, A.-P., Leroy, J., & Grenouillet, F. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit094 · Cited by 246
Invasive zygomycosis in India: experience in a tertiary care hospital
Chakrabarti, A., Chatterjee, S. S., Das, A., Panda, N., Shivaprakash, M. R., Kaur, A., Varma, S. C., Singhi, S., Bhansali, A., & Sakhuja, V (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.076463 · Cited by 244
Sangoi, A. R., Rogers, W. M., Longacre, T. A., Montoya, J. G., Baron, E. J., & Banaei, N. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp99ooozsniscz · Cited by 238
Mucormycosis in India: unique features
Chakrabarti, A., & Singh, R. (2014) · Mycoses · doi:10.1111/myc.12243 · Cited by 230
Trifilio, S., Singhal, S., Williams, S., Frankfurt, O., Gordon, L., Evens, A., Winter, J., Tallman, M., Pi, J., & Mehta, J. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705754 · Cited by 229
Slavin, M., van Hal, S., Sorrell, T. C., Lee, A., Marriott, D. J., Daveson, K., Kennedy, K., Hajkowicz, K., Halliday, C., Athan, E., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.12.021 · Cited by 188
Self-citationGuinea, J., Escribano, P., Vena, A., Muñoz, P., Martínez-Jiménez, M. D. C., Padilla, B., & Bouza, E. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179136 · Cited by 166
Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis
Lamoth, F., Chung, S. J., Damonti, L., & Alexander, B. D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix130 · Cited by 157
Auberger, J., Lass‐Flörl, C., Aigner, M., Clausen, J., Gastl, G. A., & Nachbaur, D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks189 · Cited by 156
Mucormycosis in Australia: contemporary epidemiology and outcomes
Kennedy, K., Daveson, K., Slavin, M. A., van Hal, S. J., Sorrell, T. C., Lee, A., Marriott, D. J. E., Chapman, B., Halliday, C. L., Hajkowicz, K. M., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.005 · Cited by 132
Self-citationEspinel-Ingroff, A. V., Chakrabarti, A., Chowdhary, A., Córdoba, S. B., Dannaoui, É., Dufresne, P. J., Fothergill, A. W., Ghannoum, M. A., González, G. M., Guarro, J., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04435-14 · Cited by 128
Lelièvre, L., Garcia‐Hermoso, D., Abdoul, H., Hivelin, M., Chouaki, T., Toubas, D., Mamez, A., Lantieri, L. A., Lortholary, O., & Lanternier, F. (2014) · Medicine · doi:10.1097/md.0000000000000221 · Cited by 111
Global epidemiology of cutaneous zygomycosis
Skiada, A., Rigopoulos, D., Larios, G., Petrikkos, G. L., & Katsambas, A. (2012) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2012.01.010 · Cited by 111
Outbreaks of zygomycosis in hospitals
Antoniadou, A. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02982.x · Cited by 106
Changing epidemiology of an emerging infection: zygomycosis
Meis, J. F. G. M., & Chakrabarti, A. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02973.x · Cited by 105
Bernal‐Martínez, L., Buitrago, M. J., Castelli, M. V., Rodriguez-Tudela, J. L., & Cuenca‐Estrella, M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03976.x · Cited by 99
Pagano, L., Valentini, C. G., Posteraro, B., Girmenia, C., Ossi, C. M., Pan, A. S., Candoni, A., Nosari, A., Riva, M., Cattaneo, C. M., et al. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.3.322 · Cited by 98
Molecular Phylogeny and Proposal of Two New Species of the Emerging Pathogenic FungusSaksenaea
Álvarez, E., Garcia‐Hermoso, D., Sutton, D. A., Cano, J., Stchigel, A. M., Hoinard, D., Fothergill, A. W., Rinaldi, M. G., Dromer, F., & Guarro, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01646-10 · Cited by 88
Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors
Ambrosioni, J., Bouchuiguir-Wafa, K., & Garbino, J. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.11.024 · Cited by 87
Alanio, A., Garcia‐Hermoso, D., Mercier‐Delarue, S., Lanternier, F., Gits‐Muselli, M., Ménotti, J., Denis, B., Bergeron, A., Legrand, M. M., Lortholary, O., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.01.017 · Cited by 60
Cited by
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
Singh, A. K., Singh, R., Joshi, S. R., & Misra, A. (2021) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2021.05.019 · Cited by 1,102
Global Epidemiology of Mucormycosis
Prakash, H., & Chakrabarti, A. (2019) · Journal of Fungi · doi:10.3390/jof5010026 · Cited by 938
Epidemiology and Diagnosis of Mucormycosis: An Update
Skiada, A., Pavleas, I., & Drogari-Apiranthitou, M. (2020) · Journal of Fungi · doi:10.3390/jof6040265 · Cited by 687
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India
Patel, A., Agarwal, R., Rudramurthy, S. M., Shevkani, M., Xess, I., Sharma, R., Savio, J., Sethuraman, N., Madan, S., Shastri, P., et al. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2709.210934 · Cited by 479
Metadata
- Authors
- Jeong, W., Keighley, C., Wolfe, R., Lee, W. L., Slavin, M. A., Kong, D. C. M., & Chen, S. C.-A.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 25
- Issue
- 1
- Pages
- 26-34
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2883135211
- Cited by
- 1,082
- References
- 40
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.